January 4, 2016 — Carestream Health is receiving orders for its Carestream Touch Prime and Touch Prime XE ultrasound systems in the United States and Europe, which were expected to begin shipping in December. A Health Canada license is pending.
Both premium systems are designed for general diagnostic imaging use in radiology, OB/GYN, musculoskeletal and vascular applications. Carestream demonstrated both systems at the 2015 Radiological Society of North America (RSNA) annual meeting, Nov. 29-Dec. 3 in Chicago.
These systems employ the company’s SynTek Architecture, which simultaneously provides enhanced spatial detail with increased frame rates for improved visualization of moving structures while optimizing image formation to reduce noise and artifacts. Imaging and Doppler improvements allow for more consistent visualization of subtle tissue contrast differences and can improve the ability to see small structures.
Carestream’s architecture is a significant step forward from serial line-by-line acquisition of conventional systems, according to the company. By combining information independently obtained from multiple transmissions, the new architecture synthesizes a transmit beam that is narrow not only at a single point or region in the image but over the entire spatial area, which leads to higher image quality.
The Touch Ultrasound platform’s design features a sealed, all-touch control panel that combines the speed and flexibility of a soft user interface with the tactile feedback of traditional keys. Etched marking for primary controls equips the user to easily locate key functions without looking away from the image display monitor.
The Touch Prime XE is capable of frame rates in excess of 100Hz while maintaining enhanced imaging detail, and includes optional features such as a DICOM package, barcode and badge readers as part of the system. Swipe-and-go badge log-on saves time, promotes secure access and automatically configures the system to user scanning preferences.
For more information: www.carestream.com
July 30, 2024 
